Press Releases from SuppreMol GmbH (1 total)
SuppreMol employs Protagen biomarkers in SLE study
Munich and Dortmund, Germany, August 2, 2011. SuppreMol GmbH, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases and allergies,…
Go To Page:
